Yuxian Huang

复旦大学

H指数:24

被引数:2,117

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

3D Radiomics Analysis Based on Liver CT Imaging for Predicting Hepatic Encephalopathy in HBV-ACLF Patients

基于肝脏CT成像的3D放射组学分析用于预测HBV-ACLF患者的肝性脑病

Journal of Medical Virology

IF4.6

2026-03-190

PRE

Circulating Cell-Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV-Related Acute-on-Chronic Liver Failure

循环游离线粒体DNA作为HBV相关慢加急性肝衰竭患者的预后生物标志物

Journal of Medical Virology

IF4.6

2025-08-180

PRE

Evaluation of urinary hepatitis E virus antigen colloidal gold immunochromatographic assay in clinical diagnosis of hepatitis E virus infection

尿源性戊型肝炎病毒抗原胶体金免疫层析法在戊型肝炎病毒感染临床诊断中的评估

Journal of Clinical Virology

IF3.4

2025-06-110

PRE

Long-term effects of peginterferon-based therapy versus nucleos(t)ide analogue monotherapy in non-cirrhotic HBeAg-positive chronic hepatitis B patients

聚乙二醇干扰素为基础的治疗与核苷（酸）类似物单药治疗在非肝硬化HBeAg阳性慢性乙型肝炎患者中的长期效果

Antiviral Research

IF4

2025-05-200

PRE

HIF-1α/LTBP2 axis activate HSCs to promote liver fibrosis by interacting with LOXL1 via the ERK pathway

HIF-1α/LTBP2轴通过ERK通路与LOXL1相互作用，激活HSCs以促进肝纤维化。

CELLULAR AND MOLECULAR LIFE SCIENCES

IF6.2

2025-04-170

Integrated analyses and a novel nomogram for the prediction of significant fi brosis in patients

ANNALS OF HEPATOLOGY

IF4.4

2025-01-011

OAAI

Advances in molecular targeted drugs in combination with CAR-T cell therapy for hematologic malignancies

分子靶向药物联合car-t细胞治疗恶性血液病的研究进展

DRUG RESISTANCE UPDATES

IF21.7

2024-05-015

OAAI

Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China

SARS-CoV-2再感染的发生率和严重程度，中国上海的多中心队列研究

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2023-08-034

PRE

Visualizing in situ viral replication across the natural history of chronic HBV infection

HEPATOLOGY COMMUNICATIONS

IF4.6

2023-04-010

OAAI

Downregulated VISTA enhances Th17 differentiation and aggravates inflammation in patients with acute-on-chronic liver failure

HEPATOLOGY INTERNATIONAL

IF6.1

2023-03-224

PRE

Single-Ascending-Dose, Food-Effect, and Multiple-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Pangenotypic Anti-Hepatitis C Virus Drug Holybuvir in Healthy Chinese Subjects

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2023-02-211

CHINAT-CD4 Score Predicts Transplant-Free Survival in Patients with Acute-on-Chronic Liver Failure

inflammation research

IF4.1

2023-01-010

Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2022-12-223

PRE

The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: A multicentre randomised controlled trial

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2022-09-205

PRE

Development and Validation of a Non-invasive Model to Predict Liver Histological Lesions in Chronic Hepatitis B Patients With Persistently Normal Alanine Aminotransferase and Detectable Viremia

FRONTIERS IN MEDICINE

IF3

2022-07-131

OAAI

A novel approach for relapsed/refractory FLT3mut+acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib (vol 21, 66, 2022)

MOLECULAR CANCER

IF33.9

2022-06-232

OAAI

Down-regulated cylindromatosis enhances NF-κB activation and aggravates inflammation in HBV-ACLF patients

EMERGING MICROBES & INFECTIONS

IF7.5

2022-06-0715

OAAI

STAT4 genetic polymorphism significantly affected HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients receiving Peginterferon-α therapy: A prospective cohort study in China

JOURNAL OF MEDICAL VIROLOGY

IF4.6

2022-06-015

PRE

A novel approach for relapsed/refractory FLT3mut+ acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CART cells and gilteritinib

MOLECULAR CANCER

IF33.9

2022-03-0429

OAAI

Venetoclax enhances NK cell killing sensitivity of AML cells through the NKG2D/NKG2DL activation pathway

维尼托克通过NKG2D/NKG2DL激活途径增强AML细胞的NK细胞杀伤敏感性

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-03-0111

PRE

Yuxian Huang

个人简介

教育背景

工作经历

荣誉奖项

研究方向